| Literature DB >> 34063678 |
Md Badrul Alam1,2, Marufa Naznin3, Syful Islam3, Fanar Hamad Alshammari1, Hee-Jeong Choi1, Bo-Rim Song1, Sunghwan Kim3,4, Sang-Han Lee1,2,5.
Abstract
The secondary metabolites profiling of Nymphaea nouchali stem (NNSE) extract was carried out using a high-resolution mass spectroscopic technique. The antioxidant effects of NNSE, as well as the underlying mechanisms, were also investigated in tert-butyl hydroperoxide (t-BHP)-stimulated oxidative stress in RAW264.7 cells. Tandem mass spectroscopy with (-) negative mode tentatively revealed the presence of 54 secondary metabolites in NNSE. Among them, phenolic acids and flavonoids were predominant. Phenolic acids (brevifolincarboxylic acid, p-coumaroyltartaric acid, niazinin B, lalioside, 3-feruloylquinic acid, and gallic acid-O-rutinoside), flavonoids (elephantorrhizol, apigenin-6-C-galactoside 8-C-arabinoside, and vicenin-2), sialic acid (2-deoxy-2,3-dehydro-N-acetylneuraminic acid), and terpenoid (α-γ-onoceradienedione) were identified in NNSE for the first time. Unbridled reactive oxygen species/nitrogen species (ROS/RNS) and redox imbalances participate in the induction and development of many oxidative stress-linked diseases. The NNSE exhibited significant free radical scavenging capabilities and was also able to reduce t-BHP-induced cellular generation in RAW264.7 cells. The NNSE prevented oxidative stress by inducing the endogenous antioxidant system and the levels of heme oxygenase-1 (HO-1) by upregulating Nrf2 through the modulation of mitogen-activated protein kinases (MAPK), such as phosphorylated p38 and c-Jun N terminal kinase. Collectively, these results indicate that the NNSE exhibits potent effects in preventing oxidative stress-stimulated diseases and disorders through the modulation of the MAPK/Nrf2/HO-1 signaling pathway. Our findings provide new insights into the cytoprotective effects and mechanisms of Nymphaea nouchali stem extract against oxidative stress, which may be a useful remedy for oxidative stress-induced disorders.Entities:
Keywords: Dillenia indica; RAW264.7 cells; antioxidant; heme oxygenase 1 (HO-1); nuclear factor erythroid 2-related factor 2
Year: 2021 PMID: 34063678 PMCID: PMC8147620 DOI: 10.3390/antiox10050719
Source DB: PubMed Journal: Antioxidants (Basel) ISSN: 2076-3921
Secondary metabolites identified in Nympheae nouchali stem using negative-mode electrospray ionization mass spectrometry (ESI-MS/MS).
| Groups | No. | Compound Name | EF | Observed | Calculated | Adducts | MS/MS Fragments | CE |
|---|---|---|---|---|---|---|---|---|
| Phenolic acids | 1 | Salicylic acid | C7H6O3 | 137.0227 | 137.0238 | [M − H]− | 93.03 | 10 |
| 2 | Methyl benzoic acid | C8H8O2 | 135.0444 | 135.0446 | 91.05 | 10 | ||
| 3 | Protocatechuic acid | C7H6O4 | 153.0186 | 153.0187 | 135.00,109.02 | 10 | ||
| 4 | Vanillic acid | C8H8O4 | 167.0344 | 167.0344 | 151.00, 123.04,107.01 | 10 | ||
| 5 | Gallic acid | C7H6O5 | 169.0134 | 169.0137 | 125.02 | 10 | ||
| 6 | Methoxygallate | C8H8O5 | 183.0290 | 183.0293 | 166.99, 139.04, 123.01, 111.01 | 30 | ||
| 7 | Brevifolincarboxylic acid | C13H8O8 | 291.0141 | 291.0140 | 247.02,219.02,203.03,191.03,175.04 | 20 | ||
| 8 | Pyrogallol gallate | C13H10O8 | 293.0300 | 293.0297 | 169.01, 125.02 | 10 | ||
| 9 | C13H12O8 | 295.0456 | 295.0453 | 163.04,149.00,145.02 | 20 | |||
| 10 | Methyl brevifolincarboxylic acid | C14H10O8 | 305.0300 | 305.0297 | 245.00,217.01, 201.01, 189.01,161.02,145.02 | 20 | ||
| 11 | Galloylglucose | C13H16O10 | 331.0667 | 331.0665 | 241.03, 211.02, 169.01, 125.02 | 20 | ||
| 12 | Niazinin B | C15H21NO6S | 342.1115 | 342.1011 | 310.07,196.04,166.03,164.01 | 20 | ||
| 13 | Lalioside | C14H18O10 | 345.0822 | 345.0822 | 301.05,211.02,183.02,165.01 | 20 | ||
| 14 | 5-O-caffeoylquinic acid | C16H18O9 | 353.0865 | 353.0872 | 309.09,191.05,179.03,173.04,161.02 | 20 | ||
| 15 | 3-Feruloylquinic acid | C17H20O9 | 367.1050 | 367.1029 | 193.05, 173.04 | 20 | ||
| 16 | Isoferulic acid 3-O-glucuronide | C16H18O10 | 369.0822 | 369.0821 | 193.05,177.04 | 10 | ||
| 17 | Ethyl 5-O-caffeoylquinic acid | C18H22O9 | 381.1204 | 381.1186 | 201.07,191.05,179.03,161.02 | 20 | ||
| 18 | Gallic acid-O-rutinoside | C19H26O14 | 477.1249 | 477.1244 | 315.07, 297.06, 283.04, 211.02, 169.01, 105.05, 125.02, 93.03 | 30 | ||
| 19 | Digalloylglucose | C20H20O14 | 483.0779 | 483.0774 | 331.06, 313.05, 303.07, 271.04, 241.03, 211.02, 169.01, 125.02 | 30 | ||
| Flavonoids | 20 | Catechin | C15H14O6 | 289.0692 | 289.0712 | [M − H]− | 245.04, 205.05,151.04,137.02 | 30 |
| 21 | Taxifolin | C15H12O7 | 303.0470 | 303.0504 | 285.04,241.05,177.01,151.04 | 20 | ||
| 22 | Elephantorrhizol | C15H14O8 | 321.0628 | 321.0616 | 303.05,169.01,151.04 | 30 | ||
| 23 | Naringenin-7-sulfate | C15H12O8S | 351.0175 | 351.0174 | 271 | 30 | ||
| 24 | Apigenin-6-C-galactoside-8-C-arabinoside | C26H28O14 | 563.1405 | 563.1400 | 545.13, 503.11, 473.10, 443.09, 383.07, 353.06 | 40 | ||
| 25 | Apigenin 6,8-di-C-glucoside (Vicenin-2) | C27H30O15 | 593.1517 | 593.1506 | 503.11,473.10, 383.07,353.06 | 40 | ||
| 26 | Quercetin-3-neohesperidoside | C27H30O16 | 609.1460 | 609.1455 | 245.04, 205.05,151.04,137.02 | 30 | ||
| Sugars | 27 | L-arabinofuranose | C5H10O5 | 149.0445 | 149.0450 | [M − H]− | 131.03, 89.02, 75.01, 71.01 | 10 |
| 28 | Glucose | C6H12O6 | 179.0553 | 179.0555 | [M − H]− | 113.02, 101.02, 89.02, 71.01 | 10 | |
| 215.0322 | 215.0324 | [M + Cl]− | 179.05, 113.02, 101.02, 89.02, 71.01 | 10 | ||||
| 217.0293 | 217.0295 | [M + K-2H]− | ||||||
| 29 | 6-O-β-D-galactopyranosyl-D-galactose | C12H22O11 | 341.1087 | 341.1083 | [M − H]− | 179.05, 113.02, 101.02, 89.02, 71.01 | 10 | |
| 377.0854 | 377.0857 | [M + Cl]− | 341.10, 179.05, 113.02, 101.02, 89.02, 71.01 | 20 | ||||
| 379.2159 | 379.2161 | [M + K-2H]− | ||||||
| Dicarboxylic acids | 30 | Succinic acid | C4H6O4 | 117.0175 | 117.0187 | [M − H]− | 99.00, 73.02 | 10 |
| 31 | Malic Acid | C4H6O5 | 133.0124 | 133.0137 | 115.00, 89.02, 71.01 | 10 | ||
| 32 | Citramalic acid | C5H8O5 | 147.0292 | 147.0293 | 133.01, 115.00, 87.00 | 20 | ||
| 33 | Hydroxyadipic acid | C6H10O5 | 161.0450 | 161.0450 | 143.03, 101.02, 99.04 | 20 | ||
| Amino acids | 34 | α-amino-β-hydroxybutyric acid | C4H9NO3 | 118.0141 | 118.0140 | [M − H]− | 100.04, 96.00, 74.02 | 10 |
| 35 | Pyroglutamic acid | C5H7NO3 | 128.0336 | 128.0347 | 82.03, 71.01, 69.00 | 20 | ||
| Flavoring agents | 36 | Maltol | C6H6O3 | 125.0227 | 125.0238 | [M − H]− | 97.03, 95.01, 83.04, 79.01, | 20 |
| 37 | Kahweofuran | C7H8OS | 139.0213 | 139.0217 | 111.02, 109.01, 68.98, 67.01 | 20 | ||
| 38 | Cetone V | C16H24O | 231.1748 | 231.1748 | 173.09, 155.08, 137.13,93.03 | 20 | ||
| Fatty acids | 39 | Methylcaproic acid | C7H14O2 | 129.0916 | 129.0915 | [M − H]− | 99.04, 85.10, 71.01, 69.07 | 20 |
| 40 | Ethyl-β-hydroxybutyric acid | C6H12O3 | 131.0696 | 131.0708 | 113.06, 87.08, 85.06 | 10 | ||
| 41 | Caprylic acid | C8H16O2 | 143.1061 | 143.1072 | 125.10, 113.06, 99.05, 85.03, | 10 | ||
| 42 | Dodecadienoic acid | C12H20O2 | 195.1384 | 195.1385 | 179.11, 161.10, 97.10, 71.09 | 30 | ||
| 43 | Dodecanoic acid | C12H24O2 | 199.1697 | 199.1698 | 181.16, 165.13, 163.11, 139.11, 135.11 | 20 | ||
| Sialic acid | 44 | 2-Deoxy-2,3-dehydro-N-acetylneuraminic acid | C11H17NO8 | 290.0877 | 290.0875 | [M − H]− | 200.05, 170.04, 128.07 | 10 |
| Terpenoid | 45 | α-γ-Onoceradienedione | C30H46O2 | 437.3421 | 437.3419 | [M − H]− | 219.17, 205.15, 95.08 | 40 |
| others | 46 | Glyceric acid | C3H6O4 | 105.0184 | 105.0187 | [M − H]− | 87.00, 75.00, 61.03 | 10 |
| 47 | Sorbic acid | C6H8O2 | 111.0443 | 111.0446 | 67.05 | 10 | ||
| 48 | Salicylaldehyde | C7H6O2 | 121.0278 | 121.0289 | 93.03, 65.03 | 30 | ||
| 49 | Methyl benzoic acid | C8H8O2 | 135.0444 | 135.0446 | 91.05 | 10 | ||
| 50 | Hydroxynicotinic acid | C6H5NO3 | 138.0189 | 138.0191 | 94.02 | 20 | ||
| 51 | Ribonic acid | C5H10O6 | 165.0395 | 165.0399 | 149.04, 105.01, 87.00, 75.00 | 10 | ||
| 52 | Shikimic acid | C7H10O5 | 173.0445 | 173.0450 | 155.03, 137.02, 111.04, 93.03 | 10 | ||
| 53 | Quinic acid | C7H12O6 | 191.0553 | 191.0555 | 173.05, 127.04, 93.03, 85.03 | 10 | ||
| 54 | N-undecanoylglycine | C13H25NO3 | 242.1756 | 242.1756 | 224.1656, 182.1550 | 20 |
EF, elemental formula, CE, collision energy.
Figure 1Phenolic acids (A) brevifolincarboxylic acid, (B) p-coumaroyltartaric acid, (C) niazinin B, (D) lalioside, (E) 3-feruloylquinic acid and (F) gallic acid-O-rutinoside were identified in NNSE by ESI-MS/MS.
Figure 2Flavonoids (A) elephantorrhizol, (B) apigenin 6-C-galactoside 8-C-arabinoside, (C) apigenin 6,8-di-C-glucoside (vicenin-2) were identified in NNSE by ESI-MS/M.
Figure 3Sialic acid (A) and terpenoid (B) were identified in NNSE by ESI-MS/MS.
Figure 4Effects of N. nouchali stem extract (NNSE) on radical scavenging. (A) DPPH-; (B) superoxide-; (C) ABTS-, and (D) hydroxyl-radical scavenging potential of NNSE. Ascorbic acid, quercetin, and gallic acid were designated as positive controls. (E) CUPRAC and FRAP; (F) ORAC assays were performed to assess the reducing power of NNSE. The ascorbic acid equivalent (µM) reducing power was computed for the CUPRAC and FRAP assays, whereas the ORAC potential is presented as mg Trolox equivalents/g. Values are expressed as the mean ± SD (n = 3), and different letters are considered statistically significant (p < 0.05) with one another. ASC, ascorbic acid; GA, gallic acid; QA, quercetin; ASCE, ascorbic acid equivalent. The different color represents the positive control and samples in each experiment.
Figure 5Attenuation of t-BHP-induced cell toxicity and intracellular ROS generation by NNSE and upregulation of antioxidant enzymes. Pretreatment of cells with NNSE and gallic acid for 12 h followed by treatment with 100 μM t-BHP for 6 h. The viable cells were counted, and the generation of cellular ROS was evaluated by (A) MTT assay and (B) DCFH-DA method, respectively. (C) Protein expression of SOD1, catalase, and GPx-1 was measured by western blot analysis. (D) The relative protein expression was quantified by Image J software. Values are expressed as the mean ± SD (n = 3), and different letters are considered statistically significant (p < 0.05) to one another. GA, gallic acid. The different color represents the model control, positive control, and samples in each experiment.
Figure 6NNSE induces phase II antioxidant enzymes through Nrf2 activation. (A) RAW 264.7 cells were treated with NNSE for 24 h, and phase II antioxidant enzyme expression was determined by immunoblotting assay. (B) RAW 264.7 cells were treated with NNSE (50 µg/mL) for various times, and the levels of cytoplasmic Keap1 and Nrf2 protein were confirmed by western blot analysis. (C) Cells were treated with NNSE and gallic acid for 4 h, and nuclear translocation of Nrf2 was measured by immunoblotting assay. Cells were treated with NNSE in the presence or absence of si-Nrf2 RNA, and the level of (D) Nrf2, and (E) HO-1, and NQO1 protein was measured by western blot analysis. (F) The relative expression of HO-1 and NQO1 protein was quantified by Image J software. Values are expressed as the mean ± SD (n = 3), and different letters are considered statistically significant (p < 0.05) to one another. GA, gallic acid.
Figure 7Activation of p38 and JNK by NNSE results in Nrf2 translocation. (A) RAW 264.7 cells were treated with NNSE (50 µg/mL) for various times, and kinase activity was determined by immunoblot assay. (B) Cells were treated with NNSE and specific inhibitors, SB239063 (p38 inhibitor) and SP600125 (JNK inhibitor), for 1 h, and Nrf2 and HO-1 protein levels were analyzed by western blot analysis. (C) Cells were treated with NNSE and the specific inhibitors, SB239063 and SP600125, and cellular ROS generation was quantified by the DCFH-DA methods. (D) Cells were treated with NNSE and CoPP (HO-1 activator), SnPP (HO-1 inhibitor), and brusatol (Nrf2 inhibitor), and cellular ROS generation was quantified by the DCFH-DA methods. Values are expressed as the mean ± SD (n = 3), and different letters are considered statistically significant (p < 0.05) to one another.